Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 10 of 38
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
NCT04464200
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
NCT04459416
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer
NCT04454450
Palbociclib and INCMGA00012 in People With Advanced Liposarcoma
NCT04438824
Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer
NCT04435444
A Study of the Life Changes Experienced by Patients With Pancreatic Cancer
NCT04427761
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers
NCT04209660
Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging
NCT04400292
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
NCT04419519
A Study of N-acetylcysteine in Patients With COVID-19 Infection
NCT04374461
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT04329325
AG-120 in People With IDH1 Mutant Chondrosarcoma
NCT04278781
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
NCT04298086
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
NCT04262154
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs
NCT04288375
Game-Based Physical Activity in Childhood Cancer Survivors
NCT04266080
Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection
NCT04241341
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
NCT04221178
A Study of the Use of Text Message Reminders to Take Palbociclib
NCT04216576
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
NCT04212013
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
NCT04204811
Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
NCT04161755
GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
NCT04192981
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
NCT04180579
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment
NCT04179162
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
NCT04174196
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
NCT04162015
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
NCT04148430
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
NCT04137536
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
NCT04106414
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
NCT04098393
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)
NCT04095234
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
NCT04042753
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer
NCT04030338
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
NCT03999710
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum
NCT04022213
Acupuncture Pilot Study for Cancer-related Cognitive Function
NCT04007770
Researching the Effect of Aerobic Exercise on Cancer
NCT03996239
Exercise Treatment With Standard Therapy for Metastatic Breast Cancer
NCT03988595
Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
NCT03954236
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
NCT03983382
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
NCT03832569
Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors
NCT03813615
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
NCT03808662
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
NCT03808077
A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)
NCT03802981
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
NCT03793140
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer
NCT03794635
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
NCT03684980
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.